A detailed history of Csenge Advisory Group transactions in Pfizer Inc stock. As of the latest transaction made, Csenge Advisory Group holds 46,900 shares of PFE stock, worth $1.23 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
46,900
Previous 45,595 2.86%
Holding current value
$1.23 Million
Previous $1.27 Million 3.72%
% of portfolio
0.08%
Previous 0.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$25.26 - $29.6 $32,964 - $38,628
1,305 Added 2.86%
46,900 $1.31 Million
Q1 2024

May 03, 2024

SELL
$25.89 - $29.73 $87,249 - $100,190
-3,370 Reduced 6.88%
45,595 $1.27 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $296,836 - $385,558
-11,360 Reduced 18.83%
48,965 $1.41 Million
Q3 2023

Nov 01, 2023

BUY
$32.09 - $37.51 $135,034 - $157,842
4,208 Added 7.5%
60,325 $2 Million
Q2 2023

Jul 20, 2023

SELL
$36.12 - $41.79 $43,199 - $49,980
-1,196 Reduced 2.09%
56,117 $2.06 Million
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $3,072 - $3,999
-78 Reduced 0.14%
57,313 $2.34 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $7,431 - $9,701
178 Added 0.31%
57,391 $2.94 Million
Q3 2022

Oct 04, 2022

SELL
$43.76 - $53.42 $144,014 - $175,805
-3,291 Reduced 5.44%
57,213 $2.5 Million
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $325,477 - $385,914
6,995 Added 13.07%
60,504 $3.17 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $177,327 - $219,730
3,876 Added 7.81%
53,509 $2.77 Million
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $266,514 - $395,062
6,450 Added 14.94%
49,633 $1.96 Million
Q3 2021

Oct 20, 2021

SELL
$39.25 - $50.42 $253,162 - $325,209
-6,450 Reduced 13.0%
43,183 $1.85 Million
Q2 2021

Jul 21, 2021

BUY
$35.91 - $40.68 $737,196 - $835,119
20,529 Added 70.54%
49,633 $1.96 Million
Q1 2021

Apr 28, 2021

SELL
$33.49 - $37.77 $275,053 - $310,205
-8,213 Reduced 22.01%
29,104 $1.07 Million
Q4 2020

Jan 26, 2021

SELL
$33.47 - $42.56 $20,115 - $25,578
-601 Reduced 1.58%
37,317 $1.37 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $36,957 - $43,359
1,164 Added 3.17%
37,918 $1.37 Million
Q2 2020

Jul 17, 2020

BUY
$30.12 - $36.54 $462,251 - $560,779
15,347 Added 71.69%
36,754 $1.2 Million
Q1 2020

Apr 21, 2020

BUY
$27.03 - $38.62 $168,559 - $240,834
6,236 Added 41.1%
21,407 $699,000
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $26,763 - $30,373
813 Added 5.66%
15,171 $594,000
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $253,162 - $328,276
-7,792 Reduced 35.18%
14,358 $516,000
Q2 2019

Jul 30, 2019

BUY
$36.98 - $41.52 $119,223 - $133,860
3,224 Added 17.03%
22,150 $959,000
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $375,712 - $412,782
-10,019 Reduced 34.61%
18,926 $803,000
Q4 2018

Feb 07, 2019

BUY
$38.47 - $43.86 $100,214 - $114,255
2,605 Added 9.89%
28,945 $1.26 Million
Q3 2018

Nov 19, 2018

BUY
$34.47 - $41.81 $423,360 - $513,510
12,282 Added 87.37%
26,340 $1.13 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $35,651 - $38,007
-1,081 Reduced 7.14%
14,058 $510,000
Q1 2018

May 10, 2018

BUY
$31.91 - $37.02 $106,483 - $123,535
3,337 Added 28.27%
15,139 $537,000
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $392,534 - $416,492
11,802
11,802 $427,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.